Has Tracy Turner, APRN received payments from drug or device companies?

Yes. Drug and device makers reported $3,432 in general payments to Tracy Turner, APRN across 98 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tracy Turner, APRN did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tracy Turner, APRN come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tracy Turner, APRN

Family · Lake Mary, FLNPI 1194449009

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.3% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,081, more than ten times the $15 reported in 2021.

$3,432in general payments, 2019–2025

Across 98 payments — averaging $35.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$743
AbbVie$649
Sun Pharmaceutical Industries Inc.$365
Amgen$262
Arcutis Biotherapeutics, Inc.$177
E.r. Squibb & Sons, L.L.C.$176
plus $1K from 15 others

What the payments were for

Food & beverage$3,13391%
Education$2999%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	17	$743
AbbVie	23	$649
Sun Pharmaceutical Industries Inc.	6	$365
Amgen	7	$262
Arcutis Biotherapeutics, Inc.	1	$177
E.r. Squibb & Sons, L.L.C.	3	$176
UCB, Inc.	3	$169
Lilly USA, LLC	6	$134
Galderma Laboratories, L.p.	2	$126
Incyte Corporation	6	$125
Sanofi	4	$109
Novartis	4	$81
Regeneron Healthcare Solutions, Inc.	2	$56
Dermavant Sciences, Inc.	2	$45
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$42
Botanix SB Inc	2	$41
Verrica Pharmaceuticals Inc.	2	$38
Mayne Pharma Commercial LLC	3	$33
Journey Medical Corporation	1	$25
Organon	1	$23
Novo Nordisk	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Rinvoq$232
ZORYVE$177
Sotyktu$129
Otezla$122
Tremfya$120
Bimzelx$112
ILUMYA$111
Winlevi$111
ABSORICA LD$111
NEMLUVIO$108

How this compares

$3,432 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Medicare billing

Part B allowed, 2024

$46,509

Medicare patients

220

Services billed

984

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ketoconazole	149	$2,980
Fluorouracil	30	$1,899
Metronidazole	19	$1,014
Triamcinolone Acetonide	52	$838
Clindamycin Phosphate	14	$602
Doxycycline Hyclate	35	$488
Mupirocin	19	$134
Mometasone Furoate	11	$131
Hydrocortisone	12	$92

Paid to pharmacies, not to this prescriber.

Other family in Lake Mary

Lewis HarringtonTampa$954K
Danielle PharesFt Lauderdale$713K
Donna OrtizOrlando$417K
Patrick SzarazMiami$327K
Deena RodneyMaitland$323K
Yamila MelendezMiami$212K
Holly BoydLand O Lakes$200K
Rachael BuschLoxahatchee$189K
Victor Tatis de la NuezMiramar$161K
Ronda CrewsJax Bch$155K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →